Newsletter Sign-Up

News

Barron’s: 6 Apartment Stocks That Get a Rise Out of High Home Prices
Real Estate Residential & Multifamily

Barron’s: 6 Apartment Stocks That Get a Rise Out of High Home Prices

Kevin Kelly / July 19, 2022
Apartments are a critical component of the RESI Index , and the overall housing market, as housing is undergoing a seismic change due to demands and demographics. Apartment constituents in the RESI index have unique...
Read More
NBC News: Extended stay hotels play the long game – HOTL
Hotel & Lodging Real Estate

NBC News: Extended stay hotels play the long game – HOTL

Kevin Kelly / February 23, 2022
We believe the hotel and lodging sector acts as an effective economic barometer as it uniquely captures both leisure and business spending across various income levels.The lodging ecosystem includes many specialized participants, and the HOTL...
Read More
HOTL Earnings: Global Travel Set to Rebound in 2022
Hotel & Lodging Real Estate

HOTL Earnings: Global Travel Set to Rebound in 2022

Kevin Kelly / February 16, 2022
The Hotel and Lodging Sector acts as an effective economic barometer as it uniquely captures both leisure and business spending across various income levels. Reuters covered the global rebound in travel stating: Marriott and Hilton,...
Read More
Barron’s: This RESI Home Rental Stock Is One Way to Play the Hot Housing Market
Real Estate Residential & Multifamily

Barron’s: This RESI Home Rental Stock Is One Way to Play the Hot Housing Market

Kevin Kelly / February 11, 2022
Kelly Intelligence believes that the residential and apartment ("multifamily") industry, via the RESI Index, is undergoing a seismic change due to demand and demographics.  RESI index constituents have unique competitive advantages of high-demand locations, industry-leading...
Read More
XDNA: 2022 is Set To Bring Exciting Developments for Gene Editing
CRISPR & Gene Editing

XDNA: 2022 is Set To Bring Exciting Developments for Gene Editing

Kevin Kelly / February 11, 2022
Last year ended difficulty for publicly traded gene editing companies but at J.P. Morgan’s virtual healthcare conference this week, gene-editing firms are saying that this year will bring exciting developments. Barron's stated: Intellia will expand...
Read More
XDNA: Pfizer and Beam Partner to Develop Treatments for 3 Genetic Diseases
CRISPR & Gene Editing

XDNA: Pfizer and Beam Partner to Develop Treatments for 3 Genetic Diseases

Kevin Kelly / January 10, 2022
The breaking news this week in gene editing was Pfizer Inc. will pay as much as $1.35 billion to partner with Beam Therapeutics Inc. on developing drugs for rare genetic diseases using base editing, a...
Read More
XDNA: CRISPR Start-Ups Are Being Courted by Big Pharma – Mammoth & Bayer
CRISPR & Gene Editing

XDNA: CRISPR Start-Ups Are Being Courted by Big Pharma – Mammoth & Bayer

Kevin Kelly / January 10, 2022
CRISPR & Gene Editing companies are making waves in 2022, including start-ups, which is validating the technology's promise on disrupting healthcare. News coming out of Berlin, Germany and Brisbane, California USA from Bayer AG and...
Read More
WSJ: RESI – Millennials Are Supercharging the Housing Market
Real Estate Residential & Multifamily

WSJ: RESI – Millennials Are Supercharging the Housing Market

Kevin Kelly / December 21, 2021
The Wall Street Journal came out with an feature, Millennials Are Supercharging the Housing Market, which focuses on "The generation that supposedly didn’t want to buy things now accounts for over half of all home-purchase...
Read More
WSJ: Soaring Rents Make It a Very Good Time to Own an Apartment Building
Real Estate Residential & Multifamily

WSJ: Soaring Rents Make It a Very Good Time to Own an Apartment Building

Kevin Kelly / October 11, 2021
The Wall Street Journal's Property Report published, Soaring Rents Make It a Very Good Time to Own an Apartment Building, on how rents have been rising at double-digit rates.  In the article, apartments stand to...
Read More
RESI: Sam Zell’s Equity Residential Partners With Toll on $1.9 Billion Apartment Deal
Real Estate Residential & Multifamily

RESI: Sam Zell’s Equity Residential Partners With Toll on $1.9 Billion Apartment Deal

Kevin Kelly / August 24, 2021
The evolving and residential housing boom continues and Bloomberg put it best: Sam Zell’s Equity Residential and the luxury homebuilder Toll Brothers Inc. have formed a partnership to develop apartments, looking to deploy $1.9 billion...
Read More

Invest Now

In today’s market, the only constant is change. Kelly ETFs gives you the access to capitalize on the constant changes in the markets in a simple, low-cost, effective way.

Invest Now

It is not possible to invest directly in an index. Exposure to an asset class represented by an index is available through investable instruments based on that index. Strategic Investments does not sponsor, endorse, sell, promote or manage any investment fund or other investment vehicle that is offered by third parties and that seeks to provide an investment return based on the performance of any index. Strategic Investments licenses its indices to third parties for the creation of investment funds or other vehicles, such as exchange-traded funds (ETFs), exchange-traded notes (ETNs), institutional asset mandates, and structured notes.

The information contained does not reflect the performance of any fund or account managed or serviced by Strategic Investments, and there is no guarantee that investors will experience the type of performance reflected above. There is no guarantee that any historical trend illustrated herein will be repeated in the future, and there is no way to predict precisely when such a trend will begin. There is no guarantee that any market forecast made in this commentary will be realized. The mention of specific securities is not a recommendation or solicitation for any person to buy, sell or hold any particular security and should not be relied upon as investment advice. The views and opinions in the preceding commentary are as of the date of publication and are subject to change without notice. This material represents an assessment of the market environment at a specific point in time, should not be relied upon as investment advice, is not intended to predict or depict performance of any investment and does not constitute a recommendation or an offer for a particular security. We consider the information in this presentation to be accurate, but we do not represent that it is complete or should be relied upon as the sole source of suitability for investment.